Literature DB >> 2830663

Elevated thalamic dopamine: possible link to sensory dysfunctions in schizophrenia.

A F Oke1, R N Adams.   

Abstract

Sensory-processing dysfunctions, deficit states, and the combinations of seemingly disparate behavioral symptoms of schizophrenia are addressed with regard to a common thread--the possibility of dysfunctional processing in the thalamus. Recent views of the connectional neuroanatomy and electrical activity of thalamus are examined. A hypothesis is presented in which disturbances in the timing and phasic neuronal activity of the thalamus and, especially, its connections with other brain regions may result in many of the behavioral manifestations of schizophrenia. It is suggested that neurotransmitter or other chemical imbalances might produce such thalamic disturbances. Experimental findings of enhanced dopamine content in the thalami of schizophrenic patients are reported. Several varieties of distributional patterns of this elevated dopamine are shown and evaluated.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2830663     DOI: 10.1093/schbul/13.4.589

Source DB:  PubMed          Journal:  Schizophr Bull        ISSN: 0586-7614            Impact factor:   9.306


  10 in total

1.  The primate thalamus is a key target for brain dopamine.

Authors:  Miguel Angel Sánchez-González; Miguel Angel García-Cabezas; Beatriz Rico; Carmen Cavada
Journal:  J Neurosci       Date:  2005-06-29       Impact factor: 6.167

2.  Effects of neonatal excitotoxic lesions in ventral thalamus on social interaction in the rat.

Authors:  Rainer Wolf; Henrik Dobrowolny; Sven Nullmeier; Bernhard Bogerts; Herbert Schwegler
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2017-03-30       Impact factor: 5.270

3.  Dopamine in the thalamus: a hotbed for psychosis?

Authors:  Bita Moghaddam
Journal:  Biol Psychiatry       Date:  2010-07-01       Impact factor: 13.382

Review 4.  Chronic MPTP administration regimen in monkeys: a model of dopaminergic and non-dopaminergic cell loss in Parkinson's disease.

Authors:  Gunasingh J Masilamoni; Yoland Smith
Journal:  J Neural Transm (Vienna)       Date:  2017-08-31       Impact factor: 3.575

Review 5.  Basal ganglia pathology in schizophrenia: dopamine connections and anomalies.

Authors:  Emma Perez-Costas; Miguel Melendez-Ferro; Rosalinda C Roberts
Journal:  J Neurochem       Date:  2010-01-20       Impact factor: 5.372

6.  Convergent Inputs from the Hippocampus and Thalamus to the Nucleus Accumbens Regulate Dopamine Neuron Activity.

Authors:  Stephanie M Perez; Daniel J Lodge
Journal:  J Neurosci       Date:  2018-10-24       Impact factor: 6.167

Review 7.  The mediodorsal thalamic nucleus and schizophrenia.

Authors:  Raúl Alelú-Paz; José Manuel Giménez-Amaya
Journal:  J Psychiatry Neurosci       Date:  2008-11       Impact factor: 6.186

8.  Behavioral and frontal cortical metabolic effects of apomorphine and muscimol microinjections into the mediodorsal thalamic nucleus.

Authors:  K A Young; P B Hicks; P K Randall; R E Wilcox
Journal:  J Neural Transm Gen Sect       Date:  1994

9.  Dopamine D2 receptor levels in striatum, thalamus, substantia nigra, limbic regions, and cortex in schizophrenic subjects.

Authors:  Robert M Kessler; Neil D Woodward; Patrizia Riccardi; Rui Li; M Sib Ansari; Sharlett Anderson; Benoit Dawant; David Zald; Herbert Y Meltzer
Journal:  Biol Psychiatry       Date:  2009-02-28       Impact factor: 13.382

10.  Orexin receptor antagonists reverse aberrant dopamine neuron activity and related behaviors in a rodent model of stress-induced psychosis.

Authors:  Hannah B Elam; Stephanie M Perez; Jennifer J Donegan; Daniel J Lodge
Journal:  Transl Psychiatry       Date:  2021-02-08       Impact factor: 7.989

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.